Free Trial

PaxMedica (PXMD) Competitors

PaxMedica logo

PXMD vs. AMPE, CALA, CMRA, EFTR, CLVR, ONCSQ, SMFL, ATNFW, LBPSW, and AEHAW

Should you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), Comera Life Sciences (CMRA), eFFECTOR Therapeutics (EFTR), Clever Leaves (CLVR), OncoSec Medical (ONCSQ), Smart for Life (SMFL), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), and Aesther Healthcare Acquisition (AEHAW). These companies are all part of the "pharmaceutical products" industry.

PaxMedica vs.

Ampio Pharmaceuticals (NYSE:AMPE) and PaxMedica (NASDAQ:PXMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk.

In the previous week, Ampio Pharmaceuticals had 1 more articles in the media than PaxMedica. MarketBeat recorded 1 mentions for Ampio Pharmaceuticals and 0 mentions for PaxMedica. Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled PaxMedica'saverage media sentiment score.

Company Overall Sentiment
Ampio Pharmaceuticals Neutral
PaxMedica Neutral

PaxMedica received 1 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 100.00% of users gave PaxMedica an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Ampio PharmaceuticalsOutperform Votes
No Votes
Underperform Votes
78
100.00%
PaxMedicaOutperform Votes
1
100.00%
Underperform Votes
No Votes

5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.9% of PaxMedica shares are owned by institutional investors. 3.3% of Ampio Pharmaceuticals shares are owned by insiders. Comparatively, 1.0% of PaxMedica shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ampio PharmaceuticalsN/AN/A-$8.63M-$11.010.00
PaxMedicaN/AN/A-$18.29MN/AN/A

Ampio Pharmaceuticals has a beta of 3.9, indicating that its stock price is 290% more volatile than the S&P 500. Comparatively, PaxMedica has a beta of -1.32, indicating that its stock price is 232% less volatile than the S&P 500.

Ampio Pharmaceuticals' return on equity of 0.00% beat PaxMedica's return on equity.

Company Net Margins Return on Equity Return on Assets
Ampio PharmaceuticalsN/A N/A N/A
PaxMedica N/A -3,167.89%-560.35%

Summary

Ampio Pharmaceuticals beats PaxMedica on 7 of the 9 factors compared between the two stocks.

Get PaxMedica News Delivered to You Automatically

Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

PXMD vs. The Competition

MetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1,000.00$6.48B$5.32B$8.32B
Dividend YieldN/A2.64%5.20%4.10%
P/E RatioN/A8.5626.7119.61
Price / SalesN/A257.54394.06120.47
Price / CashN/A65.8538.3234.62
Price / BookN/A6.386.744.48
Net Income-$18.29M$143.98M$3.23B$248.32M

PaxMedica Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PXMD
PaxMedica
N/AN/AN/AN/A$1,000.00N/A0.002
AMPE
Ampio Pharmaceuticals
N/A$0.00
+3.3%
N/A-98.8%$4,000.00N/A0.0020Gap Up
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-97.0%$3,000.00N/A0.0060
CMRA
Comera Life Sciences
N/AN/AN/AN/A$3,000.00$1.00M0.002
EFTR
eFFECTOR Therapeutics
N/A$0.00
flat
N/A-100.0%$3,000.00$3.55M0.0010Upcoming Earnings
CLVR
Clever Leaves
N/A$0.00
flat
N/A-100.0%$1,000.00$17.42M0.00560
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$1,000.00N/A0.0040
SMFL
Smart for Life
N/A$0.00
-98.9%
N/A-99.7%$1,000.00$11.11M0.00110Gap Down
ATNFW
180 Life Sciences
N/A$0.01
+18.8%
N/A+7.1%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
-84.6%
N/AN/A$0.00N/A0.002Gap Down

Related Companies and Tools


This page (NASDAQ:PXMD) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners